AJAC  Vol.6 No.6 , May 2015
Field-Deployable Raman Anti-Counterfeit Screening of Tamiflu Capsules
Abstract: In an effort to promote the availability of safe and effective drugs, the US Food and Drug Administration is developing spectroscopic methods to assess the quality of drugs in the field. Here we report a rapid screening classification method for Tamiflu (oseltamivir phosphate) capsules using a portable Raman spectrometer to perform screening on three solid oral dosage strengths of Tamiflu, 30 mg, 45 mg and 75 mg. Tamiflu is an antiviral drug that is stockpiled for use in the event of pandemic influenza outbreak. The qualitative classification methods reported were developed using the Raman spectra of intact capsules. The classification algorithms used were able to reliably distinguish the three dosage strengths of Tamiflu. These qualitative models are validated with additional Tamiflu samples from different batches and simulated counterfeits of Tamiflu. The probability that a test sample belongs to each dosage strength class is calculated, and strict class predictions are used to assign each sample to a particular class. The classification methods reported here enable development of user-independent, field-deployable methods for finished drug products and are able to correctly assign 92% of the validation samples using authentic Tamiflu and 100% of the simulated counterfeits.
Cite this paper: Loethen, Y. and Rodriguez, J. (2015) Field-Deployable Raman Anti-Counterfeit Screening of Tamiflu Capsules. American Journal of Analytical Chemistry, 6, 559-568. doi: 10.4236/ajac.2015.66054.

[1]   Patel, A. and Gorman, S.E. (2009) Stockpiling Antiviral Drugs for the Next Influenza Pandemic. Clinical Pharmacology Therapeutics, 86, 241-243.

[2]   Degardin, K., Roggo, Y. and Margot, P. (2014) Understanding and Fighting the Medicine Counterfeit Market. Journal of Pharmaceutical and Biomedical Analysis, 87, 167-175.

[3]   Emergency Use Authorization (EUA) Review Oseltamivir Phosphate for Swine Influenza A.

[4]   Stockpiled Antivirals at or Nearing Expiration.

[5]   FDA Warns of Counterfeit Tamiflu Product.

[6]   Rodriguez, J.D., Gryniewicz-Ruzicka, C.M., Arzhantsev, S., Kauffman, J.F. and Buhse, L.F. (2014) Rapid Screening Methods for Pharmaceutical Surveillance. Science and the Law: Analytical Data in Support of Regulation in Health, Food, and the Environment, American Chemical Society, 149-168.

[7]   de Peinder, P., Vredenbregt, M.J., Visser, T. and de Kaste, D. (2008) Detection of Lipitor? Counterfeits: A Comparison of NIR and Raman Spectroscopy in Combination with Chemometrics. Journal of Pharmaceutical and Biomedical Analysis, 47, 688-694.

[8]   Degardin, K., Roggo, Y., Been, F. and Margot, P. (2011) Detection and Chemical Profiling of Medicine Counterfeits by Raman Spectroscopy and Chemometrics. Analytica Chimica Acta, 705, 334-341.

[9]   Hargreaves, M.D., Macleod, N.A., Smith, M.R., Andrews, D., Hammond, S.V. and Matousek, P. (2011) Characterisation of Transmission Raman Spectroscopy for Rapid Quantitative Analysis of Intact Multi-Component Pharmaceutical Capsules. Journal of Pharmaceutical and Biomedical Analysis, 54, 463-468.

[10]   Eigenvector Wiki: Sample Classification Predictions.

[11]   Lieber, C.A. and Mahadevan-Jansen, A. (2003) Automated Method for Subtraction of Fluorescence from Biological Raman Spectra. Applied Spectroscopy, 57, 1363-1367.

[12]   Balachandran, U. and Eror, N.G. (1982) Raman Spectra of Titanium Dioxide. Journal of Solid State Chemistry, 42, 276-282.

[13]   Weaver, A., Reiser, H., Bartis, T., Benvenuti, M., Ghosh, D., Hunckler, M., Joy, B., Koenig, L., Raddell, K. and Lierberman, M. (2013) Paper Analytical Devices for Fast Field Screening of Beta Lactam Antibiotics and Anti-Tuberculosis Pharmaceuticals. Analytical Chemistry, 85, 6453-6460.

[14]   EMC+ Online Database Tamiflu 75 mg Capsule.